Physician profile
William Weily
NPI 1912197146
$11,168.08
in general payments reported to CMS, 2019-2025
38 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,614 · 2020: $1,486 · 2021: $2,613 · 2022: $1,174 · 2023: $1,551 · 2024: $1,414 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,281.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,678.81 | 2019-2024 | Puraply, Affinity, Cygnus Dual |
| Mid-Atlantic Surgical Systems, LLC | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $1,092.74 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home |
| Abbott Laboratories | $900.04 | 2019-2025 | Proclaim, Eterna |
| Treace Medical Concepts, INC. | $887.14 | 2019-2025 | |
| Horizon Therapeutics Plc | $871.74 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $738.75 | 2020-2025 | Nuzyra |
| Amgen INC. | $634.32 | 2024-2025 | Krystexxa |
| Stryker Corporation | $233.81 | 2020-2025 | Augment Injectable, Prostep |
| Bard Peripheral Vascular, INC. | $203.69 | 2019-2020 | |
| Kerecis Limited | $185.83 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $169.90 | 2023-2024 | Purified Cortrophin Gel |
| Medtronic, INC. | $150.00 | 2025 | Hawkone |
| Osiris Therapeutics INC. | $148.33 | 2019 | |
| Bioventus LLC | $148.13 | 2019-2025 | Exogen Ultrasound Bone Healing System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $126.13 | 2020-2022 | |
| Reapplix INC. | $94.48 | 2024 | 3c Patch Kit - Box |
| Convatec INC. | $91.88 | 2022-2025 | |
| Depuy Synthes Sales INC. | $57.52 | 2025 | Motoband |
| Merck Sharp & Dohme LLC | $53.65 | 2019 | |
| Nevro Corp. | $48.44 | 2023-2024 | Senza |
| Kowa Pharmaceuticals America, INC. | $47.43 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $46.17 | 2020-2021 | |
| Tactile Systems Technology INC | $42.48 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Globus Medical, INC. | $40.17 | 2025 | Senza |
| Cashflow Solutions, LLC | $39.59 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.99 | 2025 | Jublia |
| Kci USA, INC. | $32.74 | 2022-2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Vertex Pharmaceuticals Incorporated | $31.05 | 2025 | |
| Ets Wound Care LLC | $26.22 | 2023 | |
| Nabriva Therapeutics, Plc | $23.60 | 2022 | |
| Averitas Pharma INC. | $23.07 | 2024 | Qutenza |
| Melinta Therapeutics, LLC | $15.14 | 2019 | |
| Axogen | $13.23 | 2019 | |
| Pfizer INC. | $12.64 | 2019 | |
| Abbvie INC. | $12.40 | 2021 | |
| Orthofix Medical, INC. | $10.09 | 2021 | |
| Advanced Oxygen Therapy INC. | $2.74 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Weily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.